300122 智飞生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-4.0116.47628.95435.99178.813
总资产报酬率 ROA (%)-2.4713.97818.29222.15745.108
投入资产回报率 ROIC (%)-2.7535.12626.47833.58568.572

边际利润分析
销售毛利率 (%)23.77527.38126.91633.63149.036
营业利润率 (%)-19.8248.68417.71322.88939.149
息税前利润/营业总收入 (%)-16.9119.06417.74422.82038.995
净利润/营业总收入 (%)-15.9887.74315.25019.70333.304

收益指标分析
经营活动净收益/利润总额(%)68.348127.670105.150105.691102.136
价值变动净收益/利润总额(%)0.5130.0000.0000.000-0.047
营业外收支净额/利润总额(%)0.081-0.449-0.333-0.463-0.578

偿债能力分析
流动比率 (X)2.8032.1952.3512.3742.085
速动比率 (X)1.2311.0151.8541.7681.463
资产负债率 (%)36.18239.86537.27936.22741.235
带息债务/全部投入资本 (%)31.87829.3858.0706.7633.289
股东权益/带息债务 (%)211.480237.6731,127.9531,360.2952,894.015
股东权益/负债合计 (%)174.739150.855168.247176.039142.511
利息保障倍数 (X)-5.77421.612198.853632.817547.763

营运能力分析
应收账款周转天数 (天)514.817299.184162.158157.502114.461
存货周转天数 (天)986.487296.88879.153109.195124.338